Several studies support the use of probiotics for the treatment of minor gastrointestinal problems of newborns such as colics. The pathogenesis of colics remains largely unknown although evidences suggested multiple independent causes, including modification of the gut microbiota with an increased number of gas-forming coliforms. Positive effects on newborn colics have been evidenced after administration of Lactobacillus reuteri, whereas no studies have been reported regarding the use of bifidobacteria for this purpose. The aim of this work is to select bifidobacteria to be used as probiotics in newborns for the treatment of enteric disorders with a special attention on colics. 46 Bifidobacterium strains were originally screened and, among them, 16 showed high antimicrobial activity against potential pathogens; these strains were further characterized from a taxonomic point of view for the presence and transferability of antibiotic resistances, for cytotoxic effects and adhesion to nontumorigenic gut epithelium cell lines. Moreover, their ability to stimulate gut health by increasing the metabolic activity and the immune response of epithelial cells was also studied. The results obtained allowed to identify 3 B. breve strains and a B. longum strain as potential probiotics for the treatments of enteric disorders in newborns such as infantile colics.

Bifidobacterium strains for the treatment of enteric disorders in newborns / Aloisio I.; mazzola G.; Santini C.; Biavati B.; Cencic A.; Di Gioia D.. - STAMPA. - (2012), pp. 32-32. (Intervento presentato al convegno International Conference "nutrition and health" tenutosi a Riga, Latvia nel 4-6 Settembre 2012).

Bifidobacterium strains for the treatment of enteric disorders in newborns

ALOISIO, IRENE;MAZZOLA, GIUSEPPE;SANTINI, CECILIA;BIAVATI, BRUNO;DI GIOIA, DIANA
2012

Abstract

Several studies support the use of probiotics for the treatment of minor gastrointestinal problems of newborns such as colics. The pathogenesis of colics remains largely unknown although evidences suggested multiple independent causes, including modification of the gut microbiota with an increased number of gas-forming coliforms. Positive effects on newborn colics have been evidenced after administration of Lactobacillus reuteri, whereas no studies have been reported regarding the use of bifidobacteria for this purpose. The aim of this work is to select bifidobacteria to be used as probiotics in newborns for the treatment of enteric disorders with a special attention on colics. 46 Bifidobacterium strains were originally screened and, among them, 16 showed high antimicrobial activity against potential pathogens; these strains were further characterized from a taxonomic point of view for the presence and transferability of antibiotic resistances, for cytotoxic effects and adhesion to nontumorigenic gut epithelium cell lines. Moreover, their ability to stimulate gut health by increasing the metabolic activity and the immune response of epithelial cells was also studied. The results obtained allowed to identify 3 B. breve strains and a B. longum strain as potential probiotics for the treatments of enteric disorders in newborns such as infantile colics.
2012
International Conference "Nutrition and Health", Book of Abstract
32
32
Bifidobacterium strains for the treatment of enteric disorders in newborns / Aloisio I.; mazzola G.; Santini C.; Biavati B.; Cencic A.; Di Gioia D.. - STAMPA. - (2012), pp. 32-32. (Intervento presentato al convegno International Conference "nutrition and health" tenutosi a Riga, Latvia nel 4-6 Settembre 2012).
Aloisio I.; mazzola G.; Santini C.; Biavati B.; Cencic A.; Di Gioia D.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/147871
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact